ImmunityBio ' s bladder cancer therapy wins FDA approval

The US Food and Drug Administration has approved ImmunityBio's (IBRX) bladder cancer therapy, a significant milestone for the company. ImmunityBio Executive Chairman Dr. Patrick Soon-Shiong, joins Market Domination alongside Yahoo Finance's health reporter Anjalee Khemlani to discuss the company's…#immunitybio #immunitybioexecutive #patricksoonshiong #marketdomination #yahoofinance #anjaleekhemlani #anktiva #angelsmith
Source: Reuters: Health - Category: Consumer Health News Source Type: news